P-880. State-wide Antibiogram using National Healthcare Safety Network Antimicrobial Resistance Option 2017–2023
Dipen Patel, Christopher D Evans, Melphine Harriott

TL;DR
This paper presents Tennessee's first statewide antibiogram using data from 2017 to 2023 to track antimicrobial resistance trends and support healthcare decisions.
Contribution
The novel contribution is the creation of Tennessee's first publicly available interactive statewide antibiogram using NHSN data.
Findings
E. coli was the most common organism (44%) and urine the most frequent specimen source (72%).
S. aureus susceptibility remained below 50% from 2017 to 2023, while K. pneumoniae complex showed declining piperacillin/tazobactam susceptibility.
Abstract
Antimicrobial resistance (AR) is a significant global health threat, leading to higher healthcare costs, longer hospital stays, and increased mortality rates. Antibiograms guide empiric therapy and strengthen antimicrobial stewardship programs (ASPs). However, many facilities lack facility-specific data, and facility-level antibiograms may not fully represent broader AR trends. To address this, we developed Tennessee’s first statewide antibiogram using data from the National Healthcare Safety Network (NHSN) AR Option. Organism isolates reported as susceptible, intermediate, resistant, non-susceptible, or not tested were extracted from the NHSN AR Option from 2017 to 2023. The percentage of susceptible isolates was calculated using only those tested for a specific drug, excluding intrinsically resistant organisms and those with < 30 isolates. The TN-ASP team, including an antimicrobial…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAntibiotic Use and Resistance · Urinary Tract Infections Management · Bacterial Identification and Susceptibility Testing
